Candida auris in an Australian health care facility: importance of screening high risk patients

• 1 Victorian Healthcare Associated Infection Surveillance Coordinating Centre, Melbourne, VIC
• 2 National Centre for Infections in Cancer, Melbourne, VIC
• 3 Peter MacCallum Cancer Centre, Melbourne, VIC
• 4 Victorian Department of Health and Human Services, Melbourne, VIC
• 5 Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC
• 6 University of Melbourne, Melbourne, VIC
• 7 Microbiological Diagnostic Unit Public Health Laboratory, Doherty Institute, Melbourne, VIC

---

• 1. Eyre DW, Sheppard AE, Madder H, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 2018; 379: 1322–1331.
• 2. Chow NA, Muñoz JF, Gade L, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. mBio 2020; 11. e03364‐19.
• 3. Osei Sekyere J. Candida auris: a systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen. Microbiologyopen 2018; 7: e00578.
• 4. Ruiz‐Gaitan A, Moret AM, Tasias‐Pitarch M, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses 2018; 61: 498–505.
• 5. Heath CH, Dyer JR, Pang S, et al. Candida auris sternal osteomyelitis in a man from Kenya visiting Australia, 2015. Emerg Infect Dis 2019; 25: 192–194.
• 6. Centers for Disease Control and Prevention. Infection prevention and control for Candida auris. Atlanta, GA: CDC, 2018. https://www.cdc.gov/funga​l/candi​da-auris/​c-auris-infec​tion-contr​ol.html (viewed Oct 2018).
• 7. Public Health England. Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. August 2017 v2.0. London: PHE, 2017. https://assets.publi​shing.servi​ce.gov.uk/gover​nment/​uploa​ds/syste​m/uploa​ds/attac​hment_data/file/63768​5/Updat​ed_Candi​da_auris_Guida​nce_v2.pdf (viewed Oct 2018).